Saccharomyces boulardii Inhibits ERK1/2 Mitogen-activated Protein Kinase Activation Both in Vitro and in Vivo and Protects against Clostridium difficile Toxin A-induced Enteritis
- 1 August 2006
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 281 (34), 24449-24454
- https://doi.org/10.1074/jbc.m605200200
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Saccharomyces boulardii produces a soluble anti-inflammatory factor that inhibits NF-κB-mediated IL-8 gene expressionBiochemical and Biophysical Research Communications, 2006
- Saccharomyces boulardiiInterferes with EnterohemorrhagicEscherichia coli-Induced Signaling Pathways in T84 CellsInfection and Immunity, 2003
- Neurokinin-1 (NK-1) receptor is required in Clostridium difficile- induced enteritis.Journal of Clinical Investigation, 1998
- Effect of Saccharomyces boulardii against experimental oral infection with Salmonella typhimurium and Shigella flexneri in conventional and gnotobiotic miceJournal of Applied Bacteriology, 1996
- A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian CellsScience, 1994
- The stress-activated protein kinase subfamily of c-Jun kinasesNature, 1994
- Characterization of rabbit ileal receptors for Clostridium difficile toxin A. Evidence for a receptor-coupled G protein.Journal of Clinical Investigation, 1991
- Enterotoxins from Clostridium difficile; diarrhoeogenic potency and morphological effects in the rat intestine.Gut, 1990
- Nosocomial Acquisition ofClostridium difficileInfectionNew England Journal of Medicine, 1989
- Antibiotic-Associated Pseudomembranous Colitis Due to Toxin-Producing ClostridiaNew England Journal of Medicine, 1978